Inclusion Criteria:  Ages 12 to </= 20 years at study entry Obesity (BMI >/= the 95th percentile for age and sex) HgbA1c >/= 6.5% at type 2 diabetes diagnosis Negative diabetes auto-antibodies No history of pancreatitis No family or personal history of Multiple Endocrine Neoplasia-1 (MEN-1) No family or personal history of thyroid cancer  Exclusion Criteria:  Pregnancy or lactation Newly-initiated or change in dose of weight altering medication within past 6 months Current use of phentermine or topiramate for weight loss Current use or previous (within 12 months) use of glucagon-like peptide-1 receptor agonist (GLP-1 RA) Current or prior use of dipeptidyl peptidase-4 inhibitors (DPP-Ivi) within 12 months Current use of sulfonylureas Non-English or Spanish speaking participants